AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a supplier of custom and complex drug development services and products to the branded and generic pharma industry.   Cedarburg, located in Grafton, WI, has expertise in developing technically differentiated APIs, with core capabilities in controlled substances, s...